Las Vegas, NV—Speaking from SupplySide West, here, the day after the election, Michael McGuffin, president of the American Herbal Products Association, predicted how the results could affect the industry in the near term.
Washington, D.C.—Most Americans (68%) take dietary supplements and 85% are confident in their safety, quality and efficacy, according to the 2012 Council for Responsible Nutrition (CRN) Consumer Survey on Dietary Supplements.
Anaheim, CA—A study released on Wednesday at the American Association for Cancer Research conference in Anaheim announced that multivitamin use might decrease risks of cancer. Research performed by the National Institute of Health indicated that older males who took a multivitamin over the course of 10 years developed 8% fewer cancers than those taking a placebo pill.
Columbus, OH—A recent study at The Ohio State University on omega-3 fatty acids shows that these “good fats” do more than just fight inflammation; they may actually slow down aspects of aging. Jan Keicolt-Glaser, professor and lead author of the study, found that when overweight adults consumed an omega-3 supplement for four months, telomeres, or segments of their DNA, were preserved greater than people taking a placebo.
The Government Accountability Office and the U.S. Food and Drug Administration (FDA) recently released a report in responses to growing concerns about dietary supplements and their structure/function claims. In this report, FDA acquired 127 supplements, analyzed their structure/function claims and investigated how they substantiate such claims.
Rockville, MD—While many Americans have been cutting back their spending during the recession, nutritional supplements are one area that has not been affected. In fact, according to the report released by Packaged Facts, Nutritional Supplements in the U.S., supplement sales increased 7% to $11.5 billion in 2012, and are projected to reach $15.5 billion by 2017.
Washington, D.C.—Industry members have had some positive things to say about a new bill aimed at stopping the manufacturing, selling and marketing of illegal anabolic steroids masquerading as supplements and similar imitation drugs.